Achaogen, Inc. Asset Turnover Ratio (AKAO), as of fourth quarter 2018, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Achaogen, Inc.  (AKAO)
 

Achaogen Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Achaogen, Inc. asset turnover ratio, the ability of Achaogen, Inc.'s assets to generate revenue in the fourth quarter 2018, increased sequentially to 0.07 in the fourth quarter (Dec 31 2018), yet the ratio remained below the average, as AKAO's position remain challenging.

Within sector 62 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2018 compared to the preceding quarter from 1096 to 1268.

Asset Turnover Ratio Definition



AKAO Asset Turnover Ratio (Dec 31 2018)
IV. Quarter
(Sep 30 2018)
III. Quarter
(Jun 30 2018)
II. Quarter
(Mar 31 2018)
I. Quarter
(Dec 31 2017)
IV. Quarter
Y / Y Asset Change -58.24 % -57.71 % -45.78 % 17.52 % -23.38 %
Y / Y Revenue Change 8.35 % 246.27 % 102.37 % -71.29 % -82.59 %
Asset Turnover Ratio (TTM) 0.07 0.06 0.04 0.03 0.05
AKAO's Total Ranking # 1268 # 1096 # 3898 # 2690 # 2712
Seq. Asset Change -15.43 % -31.81 % -22.07 % -7.09 % -14.35 %
Seq. Revenue Change 1.35 % -22.01 % 19.55 % 14.66 % 223.92 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 63
Healthcare Sector # 101
Overall Market # 1268

Asset Turnover Ratio Statistics
High Average Low
10.75 5.38 3.92
(Dec 31 2018)   (Dec 31 2014)







Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2018, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2018 Assets at quarter ending Dec 31 2018
Surgalign Holdings Inc   0.29 $ 139.710  Millions$ 479.644  Millions
Teva Pharmaceutical Industries Limited  0.29 $ 18,854.000  Millions$ 65,488.750  Millions
Dmk Pharmaceuticals Corporation  0.29 $ 15.087  Millions$ 52.931  Millions
Ionis Pharmaceuticals Inc   0.28 $ 599.674  Millions$ 2,115.643  Millions
Airxpanders Inc  0.28 $ 7.817  Millions$ 27.774  Millions
Biocept Inc   0.28 $ 3.250  Millions$ 11.585  Millions
Medicure Inc   0.28 $ 22.298  Millions$ 79.481  Millions
Aratana Therapeutics, Inc.  0.28 $ 35.412  Millions$ 127.222  Millions
Zymeworks Inc   0.28 $ 53.019  Millions$ 190.834  Millions
Agenus Inc  0.28 $ 36.784  Millions$ 132.407  Millions
Endo International Plc  0.28 $ 2,947.078  Millions$ 10,611.459  Millions
Avalo Therapeutics Inc   0.28 $ 18.327  Millions$ 66.342  Millions
Viewray Inc   0.28 $ 80.962  Millions$ 293.384  Millions
Aptevo Therapeutics Inc   0.27 $ 23.067  Millions$ 84.159  Millions
Travere Therapeutics Inc   0.27 $ 164.246  Millions$ 604.321  Millions
Jounce Therapeutics inc   0.27 $ 65.201  Millions$ 244.490  Millions
Elite Pharmaceuticals Inc   0.27 $ 7.822  Millions$ 29.395  Millions
Prestige Consumer Healthcare Inc   0.26 $ 990.716  Millions$ 3,746.910  Millions
Cti Biopharma Corp   0.26 $ 26.290  Millions$ 99.442  Millions
Aspira Women s Health inc   0.26 $ 3.053  Millions$ 11.613  Millions
Capforce Inc   0.26 $ 2.946  Millions$ 11.228  Millions
Qiagen N v   0.26 $ 1,501.848  Millions$ 5,748.332  Millions
Corindus Vascular Robotics, Inc.  0.26 $ 10.781  Millions$ 41.294  Millions
Clearday Inc   0.26 $ 1.756  Millions$ 6.798  Millions
Repligen Corp  0.26 $ 194.032  Millions$ 756.269  Millions
Spectrum Pharmaceuticals Inc   0.26 $ 109.333  Millions$ 428.077  Millions
Applied Genetic Technologies Corporation  0.25 $ 28.987  Millions$ 117.352  Millions
Bausch Health Companies Inc   0.25 $ 8,380.000  Millions$ 34,128.750  Millions
Kyntra Bio Inc   0.25 $ 212.958  Millions$ 868.442  Millions
Galapagos Nv  0.24 $ 323.496  Millions$ 1,348.870  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.